Han-Lin Hsu

456 total citations
19 papers, 352 citations indexed

About

Han-Lin Hsu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Han-Lin Hsu has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Han-Lin Hsu's work include Tuberculosis Research and Epidemiology (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Han-Lin Hsu is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Han-Lin Hsu collaborates with scholars based in Taiwan, United States and Australia. Han-Lin Hsu's co-authors include Alexander T.H. Wu, Chia-Lun Chang, Szu‐Yuan Wu, Kevin Sheng‐Po Yuan, Chao‐Wen Cheng, Jyh-Ming Chow, Jer‐Hwa Chang, Hsieh‐Chih Tsai, Ya‐Wen Cheng and William Tzu-Liang Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Clinical Microbiology and BioMed Research International.

In The Last Decade

Han-Lin Hsu

18 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han-Lin Hsu Taiwan 12 105 105 87 85 81 19 352
Rodica Maricela Anghel Romania 11 98 0.9× 113 1.1× 169 1.9× 72 0.8× 79 1.0× 74 369
Ricardo Pedrini Cruz Brazil 12 152 1.4× 89 0.8× 104 1.2× 37 0.4× 138 1.7× 23 434
Qifan Li China 10 159 1.5× 102 1.0× 105 1.2× 69 0.8× 55 0.7× 41 351
Manlio Monti Italy 12 114 1.1× 172 1.6× 195 2.2× 102 1.2× 89 1.1× 46 462
D. Spriggs United States 13 82 0.8× 62 0.6× 135 1.6× 67 0.8× 69 0.9× 22 436
Wenqian Zhang China 13 176 1.7× 77 0.7× 88 1.0× 47 0.6× 29 0.4× 28 451
Chuanliang Peng China 13 253 2.4× 138 1.3× 139 1.6× 78 0.9× 99 1.2× 41 487
Abbas Abdollahi Iran 12 205 2.0× 64 0.6× 74 0.9× 102 1.2× 176 2.2× 39 490
Stephan Baldus Germany 9 100 1.0× 71 0.7× 65 0.7× 21 0.2× 71 0.9× 29 390
Yehan Zhu China 12 199 1.9× 114 1.1× 104 1.2× 148 1.7× 35 0.4× 48 515

Countries citing papers authored by Han-Lin Hsu

Since Specialization
Citations

This map shows the geographic impact of Han-Lin Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han-Lin Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han-Lin Hsu more than expected).

Fields of papers citing papers by Han-Lin Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han-Lin Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han-Lin Hsu. The network helps show where Han-Lin Hsu may publish in the future.

Co-authorship network of co-authors of Han-Lin Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Han-Lin Hsu. A scholar is included among the top collaborators of Han-Lin Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han-Lin Hsu. Han-Lin Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Sue, Yuh‐Mou, et al.. (2021). Tuberculosis treatment delay and nosocomial exposure remain important risks for patients undergoing regular hemodialysis. Journal of Microbiology Immunology and Infection. 55(5). 926–934. 3 indexed citations
3.
Hsu, Han-Lin, Chi-Hao Tsai, Po-Lin Liao, et al.. (2021). Aryl Hydrocarbon Receptor Defect Attenuates Mitogen-Activated Signaling through Leucine-Rich Repeats and Immunoglobulin-like Domains 1 (LRIG1)-Dependent EGFR Degradation. International Journal of Molecular Sciences. 22(18). 9988–9988. 2 indexed citations
4.
Lee, Hsin‐Lun, Jeng-Fong Chiou, Peng‐Yuan Wang, et al.. (2020). Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer. Cancers. 12(11). 3394–3394. 33 indexed citations
5.
Wang, Irène, et al.. (2020). Advantage in privacy protection by using synchronous video observed treatment enhances treatment adherence among patients with latent tuberculosis infection. Journal of Infection and Public Health. 13(9). 1354–1359. 16 indexed citations
6.
7.
Hsu, Han-Lin, Po-Lin Liao, Yu‐Wen Cheng, et al.. (2019). Chloramphenicol Induces Autophagy and Inhibits the Hypoxia Inducible Factor-1 Alpha Pathway in Non-Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 20(1). 157–157. 16 indexed citations
8.
Fang, Chia-Lang, Han-Lin Hsu, Sey‐En Lin, et al.. (2018). Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma. Journal of Biomedical Science. 25(1). 53–53. 6 indexed citations
9.
Yen, Yu‐Chun, Han-Lin Hsu, Jer‐Hwa Chang, et al.. (2018). Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment. Radiotherapy and Oncology. 129(1). 52–60. 34 indexed citations
10.
Chang, Chia-Lun, Hsieh‐Chih Tsai, Jer‐Hwa Chang, et al.. (2017). Dose escalation intensity-modulated radiotherapy–based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma. Radiotherapy and Oncology. 125(1). 73–79. 73 indexed citations
11.
Lin, Yen‐Kuang, Han-Lin Hsu, Jer‐Hwa Chang, et al.. (2016). Efficacy of postoperative radiotherapy in patients with pathological stage N2 epidermal growth factor receptor wild type adenocarcinoma and squamous cell carcinoma lung cancer. Oncotarget. 8(21). 35280–35288. 6 indexed citations
12.
Hsu, Han-Lin, et al.. (2014). Evaluation of a modified direct agar proportion method for testing susceptibility of Mycobacterium tuberculosis from MGIT samples. Journal of Microbiology Immunology and Infection. 49(1). 60–65. 6 indexed citations
13.
Yang, Shun‐Fa, et al.. (2014). Annexin A2 in renal cell carcinoma: Expression, function, and prognostic significance. Urologic Oncology Seminars and Original Investigations. 33(1). 22.e11–22.e21. 37 indexed citations
14.
Liu, H. Eugene, Kuan-Jen Bai, Ming-Chih Yu, et al.. (2014). Multiple Analytical Approaches Demonstrate a Complex Relationship of Genetic and Nongenetic Factors with Cisplatin- and Carboplatin-Induced Nephrotoxicity in Lung Cancer Patients. BioMed Research International. 2014. 1–9. 15 indexed citations
15.
Ke, Tao‐Wei, et al.. (2014). MicroRNA-224 Suppresses Colorectal Cancer Cell Migration by Targeting Cdc42. Disease Markers. 2014. 1–11. 39 indexed citations
16.
Lai, Chih‐Cheng, Han-Lin Hsu, Che‐Kim Tan, et al.. (2012). Recurrent Bacteremia Caused by the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex. Journal of Clinical Microbiology. 50(9). 2982–2986. 21 indexed citations
17.
Hsu, Han-Lin, et al.. (2010). Hepatitis Associated With Prothionamide for Treatment of Multidrug-resistant Tuberculosis. Journal of the Formosan Medical Association. 109(12). 923–927. 3 indexed citations
18.
Hsu, Han-Lin, et al.. (2009). Effect of Pterygium Surgery on Refractive Spherocylinder Power and Corneal Topography. Ophthalmic surgery, lasers & imaging retina. 40(1). 32–37. 17 indexed citations
19.
Lee, Chun-Nin, Ming-Chih Yu, Kuan-Jen Bai, et al.. (2008). NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan. Lung Cancer. 64(1). 9–12. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodica Maricela Anghel Breakdown of academic impact, for papers by Ricardo Pedrini Cruz Breakdown of academic impact, for papers by Qifan Li Breakdown of academic impact, for papers by Manlio Monti Breakdown of academic impact, for papers by D. Spriggs Breakdown of academic impact, for papers by Wenqian Zhang Breakdown of academic impact, for papers by Chuanliang Peng Breakdown of academic impact, for papers by Abbas Abdollahi Breakdown of academic impact, for papers by Stephan Baldus Breakdown of academic impact, for papers by Yehan Zhu
Rankless by CCL
2026